Template:PDB Gallery/4322

• 
  1cxv: STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13)
• 
  1eub: SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR
• 
  1fls: SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
• 
  1fm1: SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
• 
  1pex: COLLAGENASE-3 (MMP-13) C-TERMINAL HEMOPEXIN-LIKE DOMAIN
• 
  1xuc: Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
• 
  1xud: Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
• 
  1xur: Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor
• 
  1you: Crystal structure of the catalytic domain of MMP-13 complexed with a potent pyrimidinetrione inhibitor
• 
  1ztq: Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033
• 
  2d1n: Collagenase-3 (MMP-13) complexed to a hydroxamic acid inhibitor
• 
  2e2d: Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2
• 
  2ow9: Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor
• 
  456c: CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID
• 
  830c: COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID